172 related articles for article (PubMed ID: 8249364)
1. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study.
Beris P; Mermillod B; Levy G; Laubriat M; Soulier-Lauper M; Tullen E; Hugli A; Miescher PA
Vox Sang; 1993; 65(3):212-8. PubMed ID: 8249364
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy.
Biesma DH; Van de Wiel A; Beguin Y; Kraaijenhagen RJ; Marx JJ
Eur J Clin Invest; 1994 Jun; 24(6):426-32. PubMed ID: 7957497
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors.
Biesma DH; Kraaijenhagen RJ; Marx JJ; van de Wiel A
Transfusion; 1993 Oct; 33(10):825-9. PubMed ID: 8236423
[TBL] [Abstract][Full Text] [Related]
5. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N
Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131
[TBL] [Abstract][Full Text] [Related]
6. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin.
Biesma DH; Marx JJ; Kraaijenhagen RJ; Franke W; Messinger D; van de Wiel A
Lancet; 1994 Aug; 344(8919):367-70. PubMed ID: 7914307
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
8. Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Baron F; Sautois B; Baudoux E; Matus G; Fillet G; Beguin Y
Exp Hematol; 2002 Jun; 30(6):546-54. PubMed ID: 12063021
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
[TBL] [Abstract][Full Text] [Related]
11. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).
Rau B; Schlag PM; Willeke F; Herfarth C; Stephan P; Franke W
Eur J Cancer; 1998 Jun; 34(7):992-8. PubMed ID: 9849445
[TBL] [Abstract][Full Text] [Related]
12. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
Mercuriali F; Gualtieri G; Sinigaglia L; Inghilleri G; Biffi E; Vinci A; Colotti MT; Barosi G; Lambertengh Deliliers G
Transfusion; 1994 Jun; 34(6):501-6. PubMed ID: 8023392
[TBL] [Abstract][Full Text] [Related]
13. Preoperative autologous donation of 6 units of blood during rh-EPO treatment.
Milbrink J; Birgegård G; Danersund A; Helmers C; Nordström L; Sandhagen B
Can J Anaesth; 1997 Dec; 44(12):1315-8. PubMed ID: 9429053
[TBL] [Abstract][Full Text] [Related]
14. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
van Iperen CE; Gaillard CA; Kraaijenhagen RJ; Braam BG; Marx JJ; van de Wiel A
Crit Care Med; 2000 Aug; 28(8):2773-8. PubMed ID: 10966249
[TBL] [Abstract][Full Text] [Related]
15. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog.
Koumegawa J; Kawahara J; Kubo K; Amano K; Wakimoto N; Takahashi K; Juji T; Takaku F
Int J Cell Cloning; 1990 Mar; 8(2):97-106. PubMed ID: 2313141
[TBL] [Abstract][Full Text] [Related]
17. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
18. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
Charuruks N; Voravud N; Limpanasithikul W
J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
[TBL] [Abstract][Full Text] [Related]
19. Potential role of recombinant human erythropoietin in the peri-surgical setting.
Goodnough LT
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():203-10. PubMed ID: 2182736
[TBL] [Abstract][Full Text] [Related]
20. Serum transferrin receptor is a marker of iron deficiency in patients included in programs for preoperative autologous blood donation.
Dimonte D; Pepe M; Silletti I; Cazzato L; Fiore R
Transfus Apher Sci; 2002 Dec; 27(3):211-6. PubMed ID: 12509215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
